Correction to: Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States
Ophthalmol Ther
.
2022 Apr;11(2):923.
doi: 10.1007/s40123-022-00467-1.
Authors
Kimberly P Cockerham
1
2
,
Lissa Padnick-Silver
3
,
Noel Stuertz
3
,
Megan Francis-Sedlak
3
,
Robert J Holt
4
Affiliations
1
Central Valley Eye Medical Group, 36 W Yokuts Avenue, Suite 2, Stockton, CA, 95207, USA.
2
Department of Ophthalmology, Stanford School of Medicine, 2454 Watson Court, Palo Alto, CA, 94303, USA.
3
Horizon Therapeutics plc, 1 Horizon Way, Deerfield, IL, 60015, USA.
4
Horizon Therapeutics plc, 1 Horizon Way, Deerfield, IL, 60015, USA. rholt@horizontherapeutics.com.
PMID:
35102515
PMCID:
PMC8927549
DOI:
10.1007/s40123-022-00467-1
No abstract available
Publication types
Published Erratum